These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7130784)

  • 1. [Biochemical estimation of post-treatment surveillance for ovarian cancer: simultaneous determination of serum C-reactive protein level and lymphocyte responses to phytohemagglutinin].
    Takizawa K; Kawana T; Kawabata M; Sakamoto S
    Nihon Gan Chiryo Gakkai Shi; 1982 Feb; 17(1):22-30. PubMed ID: 7130784
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the lymphocyte responses to phytohemagglutinin (PHA) using microquantitative peripheral whole blood culture technique in the management of patients with ovarian cancer (author's transl)].
    Takizawa K; Kawabata M; Kawana T; Shiromizu K; Sakamoto S
    Nihon Gan Chiryo Gakkai Shi; 1981 Oct; 16(6):1239-47. PubMed ID: 7334260
    [No Abstract]   [Full Text] [Related]  

  • 3. The prognostic value of serum immunosuppressive effect in patients with ovarian cancer.
    Ueda K; Toyokawa M; Nakamori H; Sako H; Umesaki N; Nakade J; Lee T; Sugawa T
    Obstet Gynecol; 1979 Apr; 53(4):480-3. PubMed ID: 440651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer.
    Macciò A; Lai P; Santona MC; Pagliara L; Melis GB; Mantovani G
    Gynecol Oncol; 1998 Jun; 69(3):248-52. PubMed ID: 9648596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Level of C-reactive protein and L-1 antitrypsin in inflammatory conditions of the adnexa uteri and in benign and malignant tumor of the ovary].
    Kapeć E; Zbroja-Sontag W; Sikorski R
    Wiad Lek; 1982 Aug; 35(11-12):703-6. PubMed ID: 6982565
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cellular immune function of patients with ovarian cancer before and after cancer therapy].
    Hamai J
    Nihon Gan Chiryo Gakkai Shi; 1985 Jul; 20(6):1146-62. PubMed ID: 3840828
    [No Abstract]   [Full Text] [Related]  

  • 7. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
    Elg SA; Hill RB; Heldman L; Ramakrishnan S
    Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cimetidine-mediated augmentation of lymphocyte responses to phytohemagglutinin in gastric cancer patients.
    Kurosu Y; Tanaka N; Furusho Y; Morita K
    Jpn J Clin Oncol; 1989 Mar; 19(1):56-61. PubMed ID: 2921818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microquantitative estimation of C-reactive protein (CRP) in sera from patients with tumors of female genital organs (author's transl)].
    Takizawa K; Kawana T; Shiromizu K; Sakamoto S
    Nihon Gan Chiryo Gakkai Shi; 1978 Dec; 13(6):712-20. PubMed ID: 744888
    [No Abstract]   [Full Text] [Related]  

  • 10. C-reactive protein concentrations and subsequent ovarian cancer risk.
    McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
    Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlative studies of lymphocyte transformation and plasma protein levels in ankylosing spondylitis.
    Kinsella TD
    J Rheumatol; 1979; 6(6):621-8. PubMed ID: 529247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of C-reactive protein in autologous plasma of cancer patients and choline phosphate in lymphocyte responses to phytohemagglutinin.
    Oishi N; Torikawa C; Ochiai H; Hokama Y
    J Reticuloendothel Soc; 1973 Sep; 14(3):242-9. PubMed ID: 4200874
    [No Abstract]   [Full Text] [Related]  

  • 13. [Usefulness of determining C-reactive protein levels for monitoring the patients with ovarian cancer].
    Markowska J; Mackiewicz A; Gallas-Grala J
    Nowotwory; 1987; 37(2):97-105. PubMed ID: 3671108
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on cell-mediated immune functions of patients with gynecologic tumors. Cytotoxic activity to human ovarian cancer cell lines and reactivity to phytohemagglutinin shown by lymphocytes.
    Fukuda Y
    Keio J Med; 1983 Dec; 32(3-4):81-98. PubMed ID: 6679586
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer.
    Hefler LA; Concin N; Hofstetter G; Marth C; Mustea A; Sehouli J; Zeillinger R; Leipold H; Lass H; Grimm C; Tempfer CB; Reinthaller A
    Clin Cancer Res; 2008 Feb; 14(3):710-4. PubMed ID: 18245530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte response to plant mitogens.
    Daunter B; Khoo SK; Mackay EV
    Gynecol Oncol; 1979 Oct; 8(2):198-203. PubMed ID: 499925
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunologic control in patients with cancer of the gastrointestinal tract].
    Payá Pardo JM; de la Fuente Perucho A; Moreno Koch MC; Pérez Cuadrado S
    Rev Esp Oncol; 1980; 27(2):231-41. PubMed ID: 7255844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum C-reactive protein in the differential diagnosis of ovarian masses.
    Hefler-Frischmuth K; Hefler LA; Heinze G; Paseka V; Grimm C; Tempfer CB
    Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):65-8. PubMed ID: 19619929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of Ca 125 levels during primary therapy.
    Markmann S; Gerber B; Briese V
    Anticancer Res; 2007; 27(4A):1837-9. PubMed ID: 17649781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Component model of human lymphocyte blast transformation stimulated by phytohemagglutinin].
    Voĭtenko VP; Pakin IuV; Cherniavskaia AA
    Tsitol Genet; 1983; 17(3):19-23. PubMed ID: 6612787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.